BUPE for Recovery Act

This bill (S 5271, BUPE for Recovery Act) temporarily removes buprenorphine products used to treat opioid use disorder from the federal Suspicious Orders Report System (SORS) during the ongoing opioid public health emergency. It directly affects patients seeking opioid treatment and pharmacies that face reporting burdens under SORS, allowing them to stock and dispense these medications more easily for 270 days after the emergency ends. The bill requires a report 90 days post-emergency to evaluate if the exemption improved access and to recommend whether buprenorphine should remain exempt permanently. It does not change current treatment rules but aims to gather data on easing regulatory barriers during the emergency.